1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for Safety and Early Clinical Outcomes of Dual-Target CD19/CD22 CAR-T Strategies in Relapsed/Refractory B-ALL: A Systematic Review and Meta-Analysis$

ALL - 1407

Safety and Early Clinical Outcomes of Dual-Target CD19/CD22 CAR-T Strategies in Relapsed/Refractory B-ALL: A Systematic Review and Meta-Analysis

Mohamed Mostafa Ibrahim

Poster Presenter: Mohamed Mostafa Ibrahim

$Thumbnail for Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma$

MM - 226

Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma

Anushareddy Muddasani

Poster Presenter: Anushareddy Muddasani

SOHO 2026 Annual Meeting

Posters by Title

Safety and Early Clinical Outcomes of Dual-Target CD19/CD22 CAR-T Strategies in Relapsed/Refractory B-ALL: A Systematic Review and Meta-Analysis

Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma

Safety and Efficacy of ABVD protocol in Pregnant Patients with Classic Hodgkin Lymphoma: A single center experience

Safety and Efficacy of Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine in Untreated Advanced-Stage Classical Hodgkin Lymphoma: A Preliminary Real-World Indian Experience

Safety and Efficacy of Odronextamab in Relapsed/Refractory B-Cell Lymphomas: A Living Systematic Review with Subtypes and Post-CAR-T Analysis

Safety and Efficacy of Polatuzumab Vedotin Combined with Bendamustine and Rituximab in Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Safety and Efficacy of Subcutaneous Daratumumab Plus VRd in Frontline Treatment of Newly Diagnosed Multiple Myeloma: A Preliminary Real-World Indian Experience

Safety and Feasibility of the CALGB 10403 Pediatric-Inspired Regimen in Adults With Acute Lymphoblastic Leukemia Older Than 40 Years

Safety and Outcomes of Patients With Classical Hodgkin's Lymphoma Who Received Immune Checkpoint Inhibitors Before Autologous Stem Cell Transplantation: A Real-World Study